Biodegradable immuno-therapeutic nanoparticles

可生物降解的免疫治疗纳米颗粒

• 批准号: DP0986357
• 负责人: Prof Magdalena Plebanski
• 金额: $ 29.08万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2009
• 资助国家: 澳大利亚
• 起止时间: 2009-03-09 至 2014-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP0986357
• 关键词: Biodegradable; immuno; therapeutic; nanoparticles

The national benefit relates directly to Promoting and Maintaining Good Health through preventative healthcare as this project will develop a new vaccine delivery platform that will contribute to preventing a host of diseases such as viral infections and malaria. The health benefits of better vaccines directly enhance a Healthy Start to Life and Ageing Well. This area of nanoparticle therapies is a global 'hot spot' and this multi-disciplinary team could make huge and rapid progressions in this area of therapeutics. New intellectual property in the area of therapeutic particle production is the cornerstone of this project and could deliver lasting economic benefits through the creation of new health products and patents.

国家利益与通过预防性医疗保健促进和保持良好健康直接相关，因为该项目将开发一个新的疫苗交付平台，有助于预防病毒感染和疟疾等多种疾病。更好的疫苗的健康益处直接增强了健康的生命开端和良好的老龄化。纳米粒子疗法的这一领域是全球的“热点”，这个多学科的团队可以在这一领域的治疗取得巨大而快速的进展。治疗颗粒生产领域的新知识产权是该项目的基石，可以通过创造新的健康产品和专利带来持久的经济效益。